欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号SK/H/0280/001
药品名称Vocasept Total (flurbiprofen)
活性成分
    • Flurbiprofen 8.75 mg
剂型Lozenge
上市许可持有人Mapaex Consumer Healthcare (Ireland) Private Limited 12 Merrion Square North Dublin 2, Co. Dublin D02 H798, Ireland
参考成员国 - 产品名称Slovak Republic (SK)
Vocasept 8,75 mg tvrdé pastilky
互认成员国 - 产品名称
    • Greece (EL)
    • Denmark (DK)
      Vocasept
    • Norway (NO)
    • Portugal (PT)
    • Bulgaria (BG)
      Vocasept
    • Finland (FI)
    • Cyprus (CY)
      Vocasept Lozenge 8.75mg
    • Latvia (LV)
    • Romania (RO)
    • Lithuania (LT)
      Flurbiprofen Mapaex 8,75 mg kietosios pastilės
    • Slovenia (SI)
    • Estonia (EE)
    • Malta (MT)
    • Hungary (HU)
    • Croatia (HR)
    • Poland (PL)
      Vocasept
    • Luxembourg (LU)
许可日期2023/03/17
最近更新日期2025/12/09
药物ATC编码
    • R02AX01 flurbiprofen
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Bibliographic
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Non Prescription (including OTC)
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase